美国医院集团(HCA)
HCA
458.84
-9.66
-2.06%
美国医院集团(HCA)
US · HCA
#238 按市值排名
上市于 1970
458.84
-9.66
-2.06%
实时 - 追踪5344个代码 - 心跳于455秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
增持
- 最近一期（2026/Q3）披露持股的机构数量减少了5家。
- 机构持股总比例上升了0.3个百分点。
机构持股
- 机构持股比例
- 94.10% +0.30pp
- 机构数量
- 1,611 -5
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund51.66%
Private Company32.97%
Hedge Fund2.99%
Public Company2.69%
Government Pension Fund1.85%
Individual/Insider1.43%
Sovereign Wealth Fund1.04%
Insurance Company0.26%
Family Office/Trust0.20%
Other4.90%
主要股东 截至 2026-04-28
Frisco Holding II
16.89% · 36.56M 股
Hercules Holding Ii, LLC
14.91% · 32.28M 股
BlackRock
6.01% · 13.00M 股
Vanguard Capital Management, LLC
5.09% · 11.01M 股
Sanders Capital, LLC
4.08% · 8.83M 股
Other
53.03%
State Street Global Advisors
3.45% · 7.47M 股
Wellington Management Group
2.17% · 4.71M 股
Capital Research
1.80% · 3.89M 股
Geode Capital Management, LLC
1.69% · 3.67M 股
First Eagle Investment Management, LLC
1.52% · 3.30M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 22次买入 · 23次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Frisco Holding II | -- | 16.89% |
| Hercules Holding Ii, LLC | -- | 14.91% |
| Samuel Hazen | Chief Executive Officer | 0.65% |
| Thomas Frist | Former Chairperson | 0.22% |
| William Frist | Director | 0.19% |
| William Rutherford | Chief Financial Officer | 0.09% |
| Jon Foster | Chief Operating Officer | 0.09% |
| Michael Marks | Officer | 0.03% |
| Christopher Wyatt | Senior Vice President | 0.02% |
| Michael Cuffe | Executive VP & Chief Clinical Officer | 0.01% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-08-31 | Michael Schlosser | Senior Vice President of Care Transformation & Innovation | Initial Statement of Beneficial | 0 | -- |
| 2026-08-25 | Michael McAlevey | Chief Legal Officer | Other Disposition | -7,769 | $429.00 |
| 2026-05-06 | Michael Marks | Officer | Other Acquisition | +3,336 | -- |
| 2026-05-06 | Michael Marks | Officer | Other Disposition | -3,336 | -- |
| 2026-04-27 | John Chidsey | Independent Director | Other Acquisition | +809 | -- |
| 2026-04-27 | Michael Michelson | Independent Director | Other Acquisition | +925 | -- |
| 2026-04-27 | Nancy-Ann DeParle | Independent Director | Other Acquisition | +509 | -- |
| 2026-04-27 | Thomas Frist | Chairperson | Other Acquisition | +1,041 | -- |
| 2026-04-27 | Hugh Johnston | Independent Director | Other Acquisition | +809 | -- |
| 2026-04-27 | Wayne Riley | Independent Director | Other Acquisition | +509 | -- |
| 2026-04-27 | William Frist | Director | Other Acquisition | +809 | -- |
| 2026-04-27 | Andrea Smith | Independent Director | Other Acquisition | +509 | -- |
| 2026-02-17 | Michael McAlevey | Chief Legal Officer | Derivative Exercise and Sale | -5,000 | $236.61–540.29 |
| 2026-02-17 | Michael McAlevey | Chief Legal Officer | Intent to Sell (Form 144) | -1,694 | $533.34 |
| 2026-02-10 | Christopher Wyatt | Senior Vice President | Open Market Disposition | -4,000 | $505.00 |
| 2026-02-10 | Jennifer Berres | Chief Human Resources Officer | Open Market Disposition | -8,020 | $503.00–526.16 |
| 2026-02-09 | Samuel Hazen | Chief Executive Officer | Sale to Issuer | -21,323 | $502.05 |
| 2026-02-09 | Samuel Hazen | Chief Executive Officer | Other Acquisition | +54,934 | -- |
| 2026-02-09 | Michael McAlevey | Chief Legal Officer | Sale to Issuer | -3,006 | $502.05 |
| 2026-02-09 | Michael McAlevey | Chief Legal Officer | Other Acquisition | +8,372 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:11 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
美国医院集团(HCA) 讨论区 0 条评论